<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001975275</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001711754</issuerCik>
      <issuerName>Inmune Bio, Inc.</issuerName>
      <secFileNumber>001-38793</secFileNumber>
      <issuerAddress>
        <com:street1>225 NE MIZNER BLVD, SUITE 640</com:street1>
        <com:city>BOCA RATON</com:city>
        <com:stateOrCountry>FL</com:stateOrCountry>
        <com:zipCode>33432</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>8589643720</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>CTI Holdings, Inc</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>THE CHARLES SCHWAB CORPORATION</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>60000</noOfUnitsSold>
      <aggregateMarketValue>960085.00</aggregateMarketValue>
      <noOfUnitsOutstanding>17945995</noOfUnitsOutstanding>
      <approxSaleDate>07/12/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>05/25/2017</acquiredDate>
      <natureOfAcquisitionTransaction>STOCK PURCHASE</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>60000</amountOfSecuritiesAcquired>
      <paymentDate>05/25/2017</paymentDate>
      <natureOfPayment>NA</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>Full Account Title: CTI HOLDINGS INC, Agent TIMOTHY SCHROEDER</remarks>
    <noticeSignature>
      <noticeDate>07/12/2023</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>11/04/2022</planAdoptionDate>
      </planAdoptionDates>
      <signature>TIMOTHY SCHROEDER</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2901}]
144
0001975275
XXXXXXXX
LIVE
0001711754
Inmune Bio, Inc.
001-38793
225 NE MIZNER BLVD, SUITE 640
BOCA RATON
FL
33432
8589643720
CTI Holdings, Inc
Director
COMMON
THE CHARLES SCHWAB CORPORATION
3000 Schwab Way
Westlake
TX
76262
60000
960085.00
17945995
07/12/2023
NASDAQ
COMMON
05/25/2017
STOCK PURCHASE
ISSUER
N
60000
05/25/2017
NA
Y
Full Account Title: CTI HOLDINGS INC, Agent TIMOTHY SCHROEDER
07/12/2023
11/04/2022
TIMOTHY SCHROEDER